medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
much enough
new product flow volum beat guidanc
full year growth encourag less clear
increment expect pt
difficult stock evalu remain rare growth stori
long runway volum top comp remark within
orthodontist commun histor slow chang growth
could arguabl support multipl somewhat higher current
pt goe reflect upsid newsflow
critic investor gain clariti evolut competit
set expert feedback though view remain fundament threat
limit chang iter bear case dtc
competit think prematur simpli overblown privat
competitor lack funding/softwar compet worst case
scenario post like pressur price class case model
anticip equal-weight rate reflect view
multipl concern expect persist growth top toughen
comp lead indic signal slow downgrad ew valuat
slow lead indic potenti pressur non-comprehens case
refer partner sdc low-end trend beyond remain
domin player critic segment market forese
futur new technolog pediatr palett expand complex
mandibular expans gener dental igo case expand
moat make discuss competit academ
exhibit case volum growth acceler new high
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
learn quarter outlook core busi
observ volum growth guidanc
suggest full-year growth impli continu
growth tougher comp appear achiev light
acceler doctor add intern ebit margin expect
flat slightli fx drive upsid histor
outperform conserv margin guidanc visibl low given
intern spend ramp teen growth sustain momentum
seen particularli intern apac teen saw growth
may room run given intern teen penetr competit
launch expect may expect
impact guidanc suggest increas invisalign
outlook latam reclassifi america region
divis realign unit transfer best practic purchas
distributor brazil last year sdc expect drive minim suppli
revenu balanc expect impact outlook
product launch itero invisalign help sustain momentum
appear strongli backfil scan receipt polici chang
consid itero growth fastest scanner growth sinc element
launch acceler scanner growth like behind element launch
china fda approv itero scanner penetr teen
mandibular advanc us launch assum model minim
includ guidanc expect pend fda evalu phase
see slow ramp begin perhap importantli igo
see broader launch drive greater gp enabl behind
minut case assess path acceler dentist uptak long
sourc upsid invisalign given underpenetr channel at-
updat estim rais revenu forecast
momentum continu elev teen/dtc advertis new product
estim contempl competit ramp low-end market
next year like counter via new product
invisalign go rais pt base
yield impli price-to-earnings multipl discount current
multipl ntm price-to-earnings
strong market augment distribut major competitor emerg
macro trend improv expect us europ at-hom
align market grow fast predic aesthet market key
beneficiari share
underli trend improv top-line growth moder
tough comp align abl retain key share among high-
volum ortho north america increas digit
intern sale continu grow clip medium term ep
growth compound-annual-growth-rate captur emerg at-hom align
opportun
competit littl tougher macro environ slow
aggress promot competit product activ us europ
us high-end spend growth stabil recoveri post-crisi
investor turn attent ip expir npv impact
addit competit at-hom align opportun emerg slowli
captur share
invisalign growth expect continu
assum increment competit despit
potenti entrant near term
new featur market support
differenti barrier entri
consum sensit remain high
invisalign typic target toward case
discretionari
interoper intraor scanner
includ siro omnicam expand
potenti custom base
appear like key beneficiari
emerg at-hom align opportun
could size core
invisalign consum appeal substanti
clear align far less disrupt
patient activ tradit brace
align offer wide array featur set
orient vari degre physician
profici patient age case sever
increas mix digit case submiss
current orthodont total
time half
inflect discretionari spend
local facil salesforc emea
apac
risk achiev price
spend us abroad
new competit entri aggress
price
loss tax deduct
exhibit case volum growth acceler new high
exhibit revenu growth rel profit growth
exhibit chang forecast
sale
sale
sale
sale
sale
sale
compani data morgan stanley research
valuat risk
exhibit ev/sal valuat vs fast growth compani
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
price target price impli price-to-earnings ep base
yield see acceler ep growth ep compound-annual-growth-rate
rang busi reap benefit agreement sdc
increas digit technolog among dentist intern market penetr
risk price target includ discretionari consum spend trend
competit entri market
compani data morgan stanley research
compani data morgan stanley research
